Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings

Because of their biocompatibility and unique magnetic properties, superparamagnetic iron oxide nanoparticles NPs (SPIONs) are recognized as some of the most prominent agents for theranostic applications. Thus, understanding the interaction of SPIONs with biological systems is important for their safe design and efficient applications. In this study, SPIONs were coated with 2 different polymers: polyvinyl alcohol polymer (PVA) and dextran. The obtained NPs with different surface charges (positive, neutral, and negative) were used as a model study of the effect of surface charges and surface polymer materials on protein adsorption using a magnetic separator. We found that the PVA-coated SPIONs with negative and neutral surface charge adsorbed more serum proteins than the dextran-coated SPIONs, which resulted in higher blood circulation time for PVA-coated NPs than the dextran-coated ones. Highly abundant proteins such as serum albumin, serotransferrin, prothrombin, alpha-fetoprotein, and kininogen-1 were commonly found on both PVA- and dextran-coated SPIONs. By increasing the ionic strength, soft- and hard-corona proteins were observed on 3 types of PVA-SPIONs. However, the tightly bound proteins were observed only on negatively charged PVA-coated SPIONs after the strong protein elution.

[1]  R. Müller,et al.  Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles , 1996 .

[2]  F. Gendron,et al.  Long term in vivo biotransformation of iron oxide nanoparticles. , 2011, Biomaterials.

[3]  X. Montet,et al.  Superparamagnetic nanoparticles - a tool for early diagnostics. , 2010, Swiss medical weekly.

[4]  Yanjiao Jiang,et al.  In-vivo studies on intraperitoneally administrated poly(vinyl alcohol). , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[5]  Frank Caruso,et al.  Emerging techniques in proteomics for probing nano-bio interactions. , 2012, ACS nano.

[6]  Taeghwan Hyeon,et al.  Ultra-large-scale syntheses of monodisperse nanocrystals , 2004, Nature materials.

[7]  A. Alavi,et al.  Opportunities and Challenges , 1998, In Vitro Diagnostic Industry in China.

[8]  Morteza Mahmoudi,et al.  Protein-Nanoparticle Interactions , 2013 .

[9]  K. Dawson,et al.  Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. , 2007, Nano letters.

[10]  Shivayogi M Hugar,et al.  An In Vivo Study , 2015 .

[11]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[12]  H. Hofmann,et al.  Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. , 2004, Journal of colloid and interface science.

[13]  Kenneth A. Dawson,et al.  Nanotoxicology: nanoparticles reconstruct lipids. , 2009, Nature nanotechnology.

[14]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[15]  Doris A Taylor,et al.  Improved Efficacy of Stem Cell Labeling for Magnetic Resonance Imaging Studies by the Use of Cationic Liposomes , 2003, Cell transplantation.

[16]  Morteza Mahmoudi,et al.  Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. , 2011, Nanoscale.

[17]  Morteza Mahmoudi,et al.  Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. , 2011, Advances in colloid and interface science.

[18]  A. Curtis,et al.  Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis , 2003, IEEE Transactions on NanoBioscience.

[19]  Giulio Caracciolo,et al.  Do plasma proteins distinguish between liposomes of varying charge density? , 2012, Journal of proteomics.

[20]  Endosperm Mobilization,et al.  MOLECULAR AND CELLULAR , 1989 .

[21]  Kenneth A. Dawson,et al.  Nanobiotechnology: Nanoparticle coronas take shape , 2011 .

[22]  Bengt Rippe,et al.  Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. , 2005, American journal of physiology. Renal physiology.

[23]  A. Curtis,et al.  Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. , 2004, Biomaterials.

[24]  K. Dawson,et al.  Detecting Cryptic Epitopes Created by Nanoparticles , 2006, Science's STKE.

[25]  A. Gupta,et al.  Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies , 2004, IEEE Transactions on NanoBioscience.

[26]  L. P. Tan,et al.  In vitro studies of magnetically enhanced transfection in COS-7 cells , 2011 .

[27]  K. Braeckmans,et al.  Limitations and caveats of magnetic cell labeling using transfection agent complexed iron oxide nanoparticles. , 2012, Contrast media & molecular imaging.

[28]  M. Mahmoudi,et al.  Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. , 2012, ACS nano.

[29]  Ajay Kumar Gupta,et al.  Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. , 2007, Nanomedicine.

[30]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[31]  Karthikeyan Subramani,et al.  Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. , 2011, Chemical reviews.

[32]  M. Mahmoudi,et al.  Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.

[33]  Sara Linse,et al.  Complete high‐density lipoproteins in nanoparticle corona , 2009, The FEBS journal.

[34]  S. Radford,et al.  Nucleation of protein fibrillation by nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[35]  Sara Linse,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[36]  Jerzy Leszczynski,et al.  Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. , 2011, Nature nanotechnology.

[37]  Kenneth A. Dawson,et al.  Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. , 2012, ACS nano.

[38]  W. Kolch,et al.  Cell Type-Specific Activation of AKT and ERK Signaling Pathways by Small Negatively-Charged Magnetic Nanoparticles , 2012, Scientific Reports.

[39]  J. Hubbell,et al.  Superparamagnetic nanoparticles as a powerful systems biology characterization tool in the physiological context. , 2008, Angewandte Chemie.

[40]  H. Hofmann,et al.  Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles. , 2007, Bioconjugate chemistry.

[41]  M. Mahmoudi,et al.  Significance of cell "observer" and protein source in nanobiosciences. , 2013, Journal of colloid and interface science.

[42]  Morteza Mahmoudi,et al.  Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. , 2012, Chemical reviews.

[43]  Dar-Bin Shieh,et al.  Iron oxide nanoparticles for targeted cancer imaging and diagnostics. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[44]  A. Curtis,et al.  Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. , 2003, Biomaterials.

[45]  Morteza Mahmoudi,et al.  Engineered nanoparticles for biomolecular imaging. , 2011, Nanoscale.

[46]  P Stroeve,et al.  Cell toxicity of superparamagnetic iron oxide nanoparticles. , 2009, Journal of colloid and interface science.

[47]  Martin Frenz,et al.  Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study , 2011, International journal of nanomedicine.

[48]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[49]  Roberto Cingolani,et al.  Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.

[50]  Sara Linse,et al.  The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. , 2007, Advances in colloid and interface science.

[51]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[52]  J. Vallée,et al.  A fast and reproducible method to quantify magnetic nanoparticle biodistribution. , 2014, The Analyst.

[53]  R. Weissleder,et al.  Delivery of virus-sized iron oxide particles to rodent CNS neurons. , 1994, Neurosurgery.

[54]  Isabelle Raynal,et al.  Superparamagnetic Contrast Agents , 2007 .

[55]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[56]  A. Curtis,et al.  Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. , 2004, Biomaterials.

[57]  M. Mahmoudi,et al.  Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles. , 2013, Nanoscale.